Abstract

A PROSPECTIVE OBSERVATIONAL STUDY ON DRUG UTILIZATION PATTERNS AND RATIONAL PRESCRIBING IN PREPARTUM CARE

Dr. Lakshmi Raj Sulochana R.*, Brindha S., Dharshini A., Dharshini V.,
Dharunyaashri G., Dr. Ganesan V.

ABSTRACT

This study investigates drug utilization patterns among prepartum patients to promote safe and rational prescribing practices during pregnancy. Pregnancy involves physiological changes that necessitate careful management to safeguard maternal and fetal health. Complications such as pre-eclampsia, gestational diabetes, anemia, infections, and hyperemesis gravidarum pose significant risks to mothers, while fetal complications include intrauterine growth restriction, preterm birth, congenital anomalies, and stillbirth. Prepartum care plays a vital role in early identification and management of these risks, but it requires prudent drug use to avoid teratogenic or adverse effects. This research analyzes prescribing trends by collecting data from pregnant women attending antenatal clinics, focusing on the frequency, types, and indications of medications prescribed during the prepartum period. The study emphasizes the necessity of adherence to clinical guidelines to ensure the appropriateness and safety of prescribed drugs. It also highlights the importance of patient counseling and continuous monitoring to prevent potential adverse outcomes. Findings reveal common medications used to manage maternal complications and underscore the critical balance between therapeutic benefits and fetal safety. This study advocates for rational drug use as an integral component of comprehensive prepartum care to optimize outcomes for both mother and fetus. The insights gained can guide healthcare providers in improving prescribing behaviors, enhancing patient education, and minimizing risks associated with drug therapy during pregnancy. Ultimately, this contributes to better health outcomes and supports the overall goal of safe maternity care.

Keywords: Drug Utilization; Prepartum Care; Pre-eclampsia; Gestational Diabetes; Teratogenicity.